SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas. The U.S. Food and Drug Administration (FDA) carried ...

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as enhanceme ...

Axplora, a German CDMO that specializes in specialty active pharmaceutical ingredients for small molecules and antibody-drug conjugates, will ...

This North American Schott plant has steadily employed a core group of people in the surrounding community, manufacturing glass-ceramic cooktop panels. Specialization in advanced-material cooktop ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.

An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study identifies and resolves molecular "bottlenecks" that have ...

Construction is already underway at Axplora's Farmabios HPAPI manufacuring facility in Italy, with completion targeted for February 2027.

A new start-up is launching out of Shanghai with $68.7 million and a plan to tackle cancer and autoimmune diseases with ...